| Matthew T Zipoli, MD | |
|
290 Baker Ave, Concord, MA 01742-2189 | |
| (978) 369-9023 | |
| (978) 371-9675 |
| Full Name | Matthew T Zipoli |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 20 Years |
| Location | 290 Baker Ave, Concord, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093784159 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emerson Hospital - | W concord, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology Associates Of Concord Inc | 6901839539 | 13 |
| Jose E Peraza Md Pllc | 6901138288 | 8 |
News Archive
"If the world scales-up HIV treatment and prevention in the next two years, a critical tipping point - in which those on treatment outnumber those newly infected with the virus - could be reached, according to the global HIV prevention advocacy organization AVAC," PlusNews reports.
The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.
B55α is one of the regulatory subunits of the PP2A phosphatase. This phosphatases has been associated to the control of many biological functions but the multiplicity of complexes that can be formed by the combination of different subunits renders this protein hard in its understanding.
The vision community is discussing with the Food and Drug Administration how vision-related patient-reported outcomes might be used in improving the labeling of ophthalmic treatments and products. The group — composed of researchers, clinicians, policymakers and representatives from industry and vision associations — attended a one-day symposium sponsored by the National Institutes of Health's National Eye Institute and the FDA on October 13, 2009.
› Verified 9 days ago
| Entity Name | Dermatology Associates Of Concord Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508964230 PECOS PAC ID: 6901839539 Enrollment ID: O20050914001078 |
News Archive
"If the world scales-up HIV treatment and prevention in the next two years, a critical tipping point - in which those on treatment outnumber those newly infected with the virus - could be reached, according to the global HIV prevention advocacy organization AVAC," PlusNews reports.
The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.
B55α is one of the regulatory subunits of the PP2A phosphatase. This phosphatases has been associated to the control of many biological functions but the multiplicity of complexes that can be formed by the combination of different subunits renders this protein hard in its understanding.
The vision community is discussing with the Food and Drug Administration how vision-related patient-reported outcomes might be used in improving the labeling of ophthalmic treatments and products. The group — composed of researchers, clinicians, policymakers and representatives from industry and vision associations — attended a one-day symposium sponsored by the National Institutes of Health's National Eye Institute and the FDA on October 13, 2009.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew T Zipoli, MD 290 Baker Ave, Concord, MA 01742-2189 Ph: (978) 369-9023 | Matthew T Zipoli, MD 290 Baker Ave, Concord, MA 01742-2189 Ph: (978) 369-9023 |
News Archive
"If the world scales-up HIV treatment and prevention in the next two years, a critical tipping point - in which those on treatment outnumber those newly infected with the virus - could be reached, according to the global HIV prevention advocacy organization AVAC," PlusNews reports.
The U.S. Food and Drug Administration today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato.
B55α is one of the regulatory subunits of the PP2A phosphatase. This phosphatases has been associated to the control of many biological functions but the multiplicity of complexes that can be formed by the combination of different subunits renders this protein hard in its understanding.
The vision community is discussing with the Food and Drug Administration how vision-related patient-reported outcomes might be used in improving the labeling of ophthalmic treatments and products. The group — composed of researchers, clinicians, policymakers and representatives from industry and vision associations — attended a one-day symposium sponsored by the National Institutes of Health's National Eye Institute and the FDA on October 13, 2009.
› Verified 9 days ago
Shelley Yang, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 54 Baker Avenue Ext Ste 305&306, Concord, MA 01742 Phone: 978-371-7010 Fax: 978-371-0522 | |
Dr. Terry P Hadley, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 290 Baker Ave, Concord, MA 01742 Phone: 978-369-9023 | |
Brandon Rowe, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 54 Baker Avenue Ext Ste 305&306, Concord, MA 01742 Phone: 351-300-0110 | |
Dr. Peter Muz, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 54 Baker Avenue Ext 305, Concord, MA 01742 Phone: 978-371-7010 | |
David E Geist, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 54 Baker Avenue Ext Ste 305, Concord, MA 01742 Phone: 978-371-7010 | |
Caroline L Levine, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 290 Baker Ave, Concord, MA 01742 Phone: 978-369-9023 Fax: 978-371-9675 |